Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma

被引:542
作者
Davis, AM
O'Sullivan, B
Turcotte, R
Bell, R
Catton, C
Chabot, P
Wunder, J
Hammond, A
Benk, V
Kandel, R
Goddard, K
Zee, B
Day, A
Tu, DS
Pater, J
机构
[1] Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[4] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[5] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada
[6] London Reg Canc Ctr, London, ON, Canada
[7] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
[8] BC Canc Agcy, Vancouver, BC, Canada
[9] Univ Toronto, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
radiotherapy; toxicity; randomized trial; extremity soft tissue sarcoma;
D O I
10.1016/j.radonc.2004.12.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Purpose: This study compared late radiation morbidity in patients with extremity soft tissue sarcoma randomized to treatment by pre- (50 Gy) or postoperative (66 Gy) radiotherapy in combination with surgery. The morbidities evaluated included fibrosis, joint stiffness and edema at 2 years following treatment. The impact of morbidity on patient function as measured by the Musculoskeletal Tumor Rating Scale (MSTS) and the Toronto Extremity Salvage Score (TESS) was also evaluated. Patients and methods: 129 patients were evaluated. Toxicity rates were compared by treatment arm using the Fisher's exact test. Function scores by toxicity were analyzed using the Wilcoxon rank sum test. Multivariate logistic regression was used to evaluate the joint effect of treatment arm, field size, and dose on subcutaneous tissue fibrosis, joint stiffness and edema. Results: 27 of 56 patients (48.2%) in the postoperative arm compared to 23 of 73 (31.5%) in the preoperative arm had grade 2 or greater fibrosis (P = 0.07). Although not statistically significant, edema was more frequent in the postoperative arm, 13 of 56 (23.2%) versus 11 of 73 (15.1%) in the preoperative arm, as was joint stiffness, 13 of 56 (23.2%) versus 13 of 73 (17.8%). Patients with significant fibrosis, joint stiffness or edema had significantly lower function scores on both measures (all P-values < 0.01). Field size was predictive of greater rates of fibrosis (P = 0.002) and joint stiffness (P = 0.006) and marginally predictive of edema (P = 0.06). Conclusions: Patients treated with postoperative radiotherapy tended to have greater fibrosis. Fibrosis, joint stiffness and edema adversely affect patient function. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:48 / 53
页数:6
相关论文
共 38 条
[1]   Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes [J].
Andreassen, CN ;
Alsner, J ;
Overgaard, M ;
Overgaard, J .
RADIOTHERAPY AND ONCOLOGY, 2003, 69 (02) :127-135
[2]  
[Anonymous], 1980, International classification of impairments, disabilities and handicaps
[3]  
[Anonymous], 2001, ICF INT CLASFUNCT
[4]   FUNCTIONAL OUTCOME IN PATIENTS TREATED WITH SURGERY AND IRRADIATION FOR SOFT-TISSUE TUMORS [J].
BELL, RS ;
OSULLIVAN, B ;
DAVIS, A ;
LANGER, F ;
CUMMINGS, B ;
FORNASIER, VL .
JOURNAL OF SURGICAL ONCOLOGY, 1991, 48 (04) :224-231
[5]  
BUJKO K, 1993, SURG GYNECOL OBSTET, V176, P124
[6]  
Chmell MJ, 1996, J SURG ONCOL, V61, P185, DOI 10.1002/(SICI)1096-9098(199603)61:3<185::AID-JSO4>3.0.CO
[7]  
2-7
[8]   TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) [J].
COX, JD ;
STETZ, J ;
PAJAK, TF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05) :1341-1346
[9]   Development of a measure of physical function for patients with bone and soft tissue sarcoma [J].
Davis, AM ;
Wright, JG ;
Williams, JI ;
Bombardier, C ;
Griffin, A ;
Bell, RS .
QUALITY OF LIFE RESEARCH, 1996, 5 (05) :508-516
[10]   Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma [J].
Davis, AM ;
O'Sullivan, B ;
Bell, RS ;
Turcotte, R ;
Catton, CN ;
Wunder, JS ;
Chabot, P ;
Hammond, A ;
Benk, V ;
Isler, M ;
Freeman, C ;
Goddard, K ;
Bezjak, A ;
Kandel, RA ;
Sadura, A ;
Day, A ;
James, K ;
Tu, D ;
Pater, J ;
Zee, B .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (22) :4472-4477